- 2 updates
Heart failure patients will be unable to give their consent to take part in a trial where they will be given a placebo rather than a standard adrenaline shot.
However, the study has been approved by the Oxford Research Ethics Committee and is funded by the National Institute for Health Research.
The first 8,000 patients to suffer a cardiac arrest out of hospital will form the sample for the trial, which will begin in Wales, the West Midlands, North East, the south coast and London this autumn.
Patients suffering heart failure could be given a placebo in place of an adrenaline shot, as part of a new study to determine the effectiveness of the drug during resuscitation.
Paramedics will have to unwittingly administer the salt water dummy drug to unknowing patients in an experiment to be carried out by Warwick University, along with the University of Surrey.
Around 50,000 people in the UK suffer a cardiac arrest, according to the university, and resuscitation attempts are successful in only one in four cases.
Cardiac arrest patients have routinely been given an adrenaline jab since the 1960s, but the team of researchers has said because it reduces blood flow to the brain, it could cause severe brain damage and even death.